Cencora Inc., US15135B1017

Cencora insider buying draws attention, shares trade higher on NYSE

23.06.2026 - 18:29:15 | ad-hoc-news.de

Director Dermot Durcan's roughly 1.1 million dollar share purchase at Cencora is in focus as COR trades above 270 dollars on the NYSE, with analysts' targets still well above the current level.

Cencora Inc., US15135B1017
Cencora Inc., US15135B1017

By Christina Vogel, Background & Management desk. Reviewed prior to publication on 2026-06-23, 18:28.

Cencora Inc. (US15135B1017) is back on traders' radar after fresh insider buying. On the NYSE, the COR shares trade around the mid-270 dollar range on Tuesday, while a director's roughly 1.1 million dollar purchase underpins sentiment according to a Nasdaq insider report. Nasdaq insider buying report

What the insider bought

On Thursday, June 18, 2026, Cencora director Dermot Mark Durcan acquired 4,000 COR shares at a price of 274.19 dollars per share, implying an investment volume of roughly 1.10 million dollars as documented in the SEC filing. GuruFocus summary of SEC filing

Following this transaction, Durcan's stake rose to 31,767 Cencora shares, according to the same analysis, highlighting continued insider exposure to the US healthcare distributor. GuruFocus summary of SEC filing

How the shares trade and what analysts say

On Tuesday, June 23, COR trades around 273 dollars on the NYSE, after moving in an intraday range between roughly 269.30 and 274.12 dollars, as shown by Robinhood price data for Cencora. Robinhood COR quote

This corresponds to a market capitalization of about 52.8 billion dollars and a price-to-earnings ratio near 20.8, while a composite of Wall Street analysts on eToro indicates an average 12-month price target around 371 dollars for the Cencora stock. eToro analyst consensus for COR

Go deeper

All news and analysis on the Cencora shares

More corporate news, analyst views and price data on Cencora can be found in the dedicated topic overview on ad-hoc-news.de and on the company's investor relations pages.

The business behind Cencora

Cencora generates the bulk of its revenue as a healthcare distributor, supplying branded, specialty and generic pharmaceuticals as well as related services to pharmacies, hospitals and physician practices in the United States and internationally, according to company and industry descriptions. MarketBeat company profile for Cencora

Where the stock trades today

The Cencora shares (US15135B1017) trade on 2026-06-23 at 18:10 on the NYSE at about 273.28 dollars.

Key data on the Cencora shares

  • Company: Cencora Inc.
  • ISIN: US15135B1017
  • WKN: A3EH5H
  • Ticker: COR
  • Trading venue: NYSE
  • Price (as of 2026-06-23, 18:10): 273.28 USD
  • Market cap: 52.81 billion USD (as of 2026-06-23)
  • Sector / industry: Health Care / Health Care Distributors
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on the Cencora shares in social media

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security.

en | US15135B1017 | CENCORA INC. | boerse | 69612236 | bgmi